Business Description
Baxter International Inc
NAICS : 339112
SIC : 3841
ISIN : US0718131099
Share Class Description:
BAX: Ordinary SharesTotal Employee Number:
37,500Compare
Compare
Traded in other countries / regions
BAX.USA0QK8.UKBTL.Germany1BAX.ItalyBAX.AustriaBAX.MexicoB1AX34.Brazil Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
1961-05-15Description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.6 | |||||
Debt-to-EBITDA | 12.92 | |||||
Interest Coverage | 0.64 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.19 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year EPS without NRI Growth Rate | -13.4 | |||||
3-Year FCF Growth Rate | -18 | |||||
3-Year Book Growth Rate | 1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 1.94 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.07 | |||||
9-Day RSI | 64.25 | |||||
14-Day RSI | 64.22 | |||||
3-1 Month Momentum % | 18.43 | |||||
6-1 Month Momentum % | -3.61 | |||||
12-1 Month Momentum % | -31.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.55 | |||||
Days Inventory | 106.69 | |||||
Days Sales Outstanding | 56.46 | |||||
Days Payable | 46.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.88 | |||||
Dividend Payout Ratio | 0.21 | |||||
3-Year Dividend Growth Rate | -23.2 | |||||
Forward Dividend Yield % | 0.88 | |||||
5-Year Yield-on-Cost % | 0.56 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 25.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.12 | |||||
Operating Margin % | 1.63 | |||||
Net Margin % | -9.7 | |||||
EBITDA Margin % | 6.63 | |||||
FCF Margin % | 6.31 | |||||
OCF Margin % | 11.05 | |||||
ROE % | -16.24 | |||||
ROA % | -5.31 | |||||
ROIC % | 1.16 | |||||
3-Year ROIIC % | -2.54 | |||||
ROC (Joel Greenblatt) % | -4.29 | |||||
ROCE % | -1.28 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 11.81 | |||||
PE Ratio without NRI | 13.27 | |||||
Shiller PE Ratio | 15.28 | |||||
PS Ratio | 1.05 | |||||
PB Ratio | 1.93 | |||||
Price-to-Free-Cash-Flow | 16.3 | |||||
Price-to-Operating-Cash-Flow | 9.34 | |||||
EV-to-EBIT | -87.45 | |||||
EV-to-Forward-EBIT | 31.18 | |||||
EV-to-EBITDA | 25.77 | |||||
EV-to-Forward-EBITDA | 12.17 | |||||
EV-to-Revenue | 1.71 | |||||
EV-to-Forward-Revenue | 1.7 | |||||
EV-to-FCF | 27.07 | |||||
Price-to-GF-Value | 0.66 | |||||
Price-to-Projected-FCF | 0.88 | |||||
Price-to-Median-PS-Value | 0.34 | |||||
Earnings Yield (Greenblatt) % | -1.14 | |||||
FCF Yield % | 6.11 | |||||
Forward Rate of Return (Yacktman) % | 14.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baxter International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 11,320 | ||
| EPS (TTM) ($) | -2.13 | ||
| Beta | 0.809 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.79 | ||
| Volatility % | 46.25 | ||
| 14-Day RSI | 64.22 | ||
| 14-Day ATR ($) | 0.737916 | ||
| 20-Day SMA ($) | 21.3235 | ||
| 12-1 Month Momentum % | -31.62 | ||
| 52-Week Range ($) | 15.73 - 29.515 | ||
| Shares Outstanding (Mil) | 516.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baxter International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baxter International Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 07:30 | In 112 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 111 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 08:30 | In 21 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 20 days | ||
| USD 0.010000 Cash Dividend | 2026-05-29 | 19.25 (+2.61%) | ||
| General meeting for 2026 | 2026-05-05 09:00 | 16.62 (-3.37%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 07:30 | 16.90 (-5.00%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 16.90 (-5.00%) | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-11 13:00 | 17.46 (-2.57%) | ||
| USD 0.010000 Cash Dividend | 2026-02-27 | 20.36 (-2.26%) |
Show
Entries
Baxter International Inc Frequently Asked Questions
What is Baxter International Inc(BAX)'s stock price today?
The current price of BAX is $22.62. The 52 week high of BAX is $29.52 and 52 week low is $15.73.
When is next earnings date of Baxter International Inc(BAX)?
The next earnings date of Baxter International Inc(BAX) is 2026-07-31 Est..
Does Baxter International Inc(BAX) pay dividends? If so, how much?
The Dividend Yield %  of Baxter International Inc(BAX) is 0.88% (As of Today), Highest Dividend Payout Ratio of Baxter International Inc(BAX) was 0.55. The lowest was 0.21. And the median was 0.37. The  Forward Dividend Yield % of Baxter International Inc(BAX) is 0.88%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:BAX
Press Release
Articles on Baxter International Inc
A Look at Baxter International Inc (BAX) After 3.9% Decline -- GF Value $34.41 vs Price $21.98
2 days ago
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges
3 days ago
Headlines
See More- 1
Jul 07, 2026
Stock futures mixed as Nasdaq futures slide on AI valuation concerns
Seeking Alpha • 3:26am
Jun 18, 2026
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
Benzinga • 9:01am
Jun 14, 2026
Notable healthcare headlines for the week: GSK, Parabilis Medicines, and Novo Nordisk in focus
Seeking Alpha • 8:05am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers